- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Viral; Infection, Slow Virus
Total 23444 results
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States, Spain, France, Canada, Portugal, Italy, Belgium
-
ViiV HealthcareGlaxoSmithKlineCompletedEffect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy SubjectsInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States
-
GlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedHealthy Subjects | Infection, Human Immunodeficiency VirusUnited States
-
GlaxoSmithKlineCompletedHealthy Subjects | Infection, Human Immunodeficiency VirusUnited States
-
Catherine BollardActive, not recruiting
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); University of Arkansas; Tata Memorial Hospital; Udaan TrustNot yet recruitingHIV InfectionUnited States, India
-
Ottawa Hospital Research InstituteCHEO Research Institute; Nebraska Centre for Substance Abuse ResearchRecruitingHIV-infection/AIDSCanada
-
University of MinnesotaNational Institute of Allergy and Infectious Diseases (NIAID); Merck Sharp...CompletedHIV Infections | HIV InfectionUnited States
-
The HIV Netherlands Australia Thailand Research...Ministry of Education, ThailandCompletedHIV Infections | HIV InfectionThailand
-
Yale UniversityNational Institute of Mental Health (NIMH); National Institute of Neurological... and other collaboratorsCompletedHIV Infections | Acute HIV InfectionThailand
-
University of California, San DiegoNational Institutes of Health (NIH); Centers for Disease Control and PreventionCompletedAcute HIV InfectionUnited States
-
Hospital Italiano de Buenos AiresCompletedHIV InfectionArgentina
-
Tufts UniversityCompletedHIV Infections | HIV Infection | Cardiovascular RiskUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionUnited States
-
BiositeInverness Medical InnovationsWithdrawnHIV Infections | HIV Infection | AIDSUnited States
-
Yale UniversityNational Institute on Drug Abuse (NIDA); Merck Sharp & Dohme LLCCompletedHIV Infections | HIV InfectionUnited States
-
FHI 360Muhimbili University of Health and Allied SciencesCompleted
-
St Stephens Aids TrustCompletedHIV Infections | HIV InfectionUnited Kingdom
-
A.O. Ospedale Papa Giovanni XXIIICompletedHIV Infections | HIV Infection
-
Hospices Civils de LyonTerminatedSelection of Farnesoid X Receptor (FXR) Ligands on the Reactivation of Latent HIV Proviruses (FXR#2)Human Immunodeficiency Virus I InfectionFrance
-
Fred Hutchinson Cancer CenterUniversity of WashingtonCompleted
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus
-
ViiV HealthcareGlaxoSmithKlineTerminatedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus
-
ViiV HealthcareCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
GlaxoSmithKlineCompleted
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited Kingdom
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
GlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States